Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.

Abstract

Intractable bleeding unresponsive to conventional haemostatic measures is an uncommon but potentially life threatening surgical complication. Several studies have suggested that recombinant factor VIIa (rVIIa), a genetically engineered substitute for endogenous factor VIIa may have therapeutic application in patients with uncontrollable haemorrhage not… (More)

Topics

Cite this paper

@article{Manning2005RecombinantFV, title={Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.}, author={Brian J. Manning and Naimh Hynes and D F Courtney and Sherif Sultan}, journal={European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery}, year={2005}, volume={30 5}, pages={525-7} }